Companies Have Discretion Over Whether to Disclose Coronavirus Infections

Companies Have Discretion Over Whether to Disclose Coronavirus Infections

March 18, 2020, The Wall Street Journal

David Martin is quoted in The Wall Street Journal regarding companies’ decisions to disclose potential COVID-19 infections of executives. Mr. Martin says that while companies have leeway on executive medical disclosures, they often have a strong incentive to provide timely information. Doing so prevents employees from leaking information and investors from raising questions about why a CEO is no longer appearing in public. According to Mr. Martin, “There’s a practical issue: Does the company feel like it has to communicate with employees?”